Study identifies promising therapy to prevent relapses in rare neurological disease
MedicalXpress,
An international study led by Mayo Clinic researchers has identified interleukin-6 (IL-6) receptor blockers as a promising…
An international study led by Mayo Clinic researchers has identified interleukin-6 (IL-6) receptor blockers as a promising…
An international study led by Mayo Clinic researchers has identified interleukin-6 (IL-6) receptor blockers as a promising…
— News and commentary from the world of neurology and neuroscience by Judy George, Deputy Managing Editor, MedPage Today July 21…